![](/img/cover-not-exists.png)
ACTR-10. A RANDOMIZED, PHASE I/II TRIAL OF IXAZOMIB IN COMBINATION WITH STANDARD THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED GLIOBLASTOMA (GBM) STUDY DESIGN
Kong, Xiao-Tang, Lai, Albert, Carrillo, Jose A, Fu, Dan Beverly, Meyskens, Frank, Bota, Daniela AVolume:
20
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noy148.045
Date:
November, 2018
File:
PDF, 89 KB
english, 2018